Total Credits: .75 including .75 AOA Category 1-A Credit(s)
In this session, we will review CKD definitions and management principles. Specific management principles discussions will include SGLT-2 inhibitors role in CKD , chlorthalidone’s role in CKD, using potassium binding resins, finerinone, and when it is ideal to refer to a nephrologist.
Upon completion of this program, participants will be able to:
Statement of Accreditation
The Texas Osteopathic Medical Association (TOMA) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. TOMA designates this program for a maximum of .75 AOA Category 1-A credits and will report CME credits commensurate with the extent of the physician’s participation in this activity.
All grievances may be directed to TOMA's Executive Director at email@example.com. All grievances will receive an initial response within 30 days of receipt. If the participant does not receive a satisfactory response, they can submit a complaint to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
|kabani_am22 handout (2.40 MB)||Available after Purchase|
Dr. Khadija Kabani is board certified in family medicine in Dallas. Dr. Kabani graduated from University of North Texas Health Science Center Texas College of Osteopathic Medicine in 2005 and has been in practice for 13 years. She currently practices at Methodist Dallas Medical Center.
Dr. Kabani discloses that she has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.
Dr. Richard Fuquay is a general nephrologist with Dallas Nephrology Associates in the DeSoto office near Methodist Charlton Medical Center. He has an interest in peritoneal dialysis, resistant hypertension, and nutrition through the kidney disease process. He can be reached at firstname.lastname@example.org.
Dr. Fuquay discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.